Navigation Links
Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
Date:5/4/2012

ted to have ADHD.

The specific etiology of ADHD is unknown, and there is no single diagnostic test for this disorder. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources, utilizing diagnostic criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR®) or International Classification of Diseases, Tenth Revision (ICD-10).

Although there is no cure for ADHD, there are accepted treatments that have been demonstrated to improve symptoms. Standard treatments include educational approaches, psychological therapies which may include behavioral modification, and/or medication.

Notes to editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

Vyvanse® is a registered trademark of Shire LLC.

Venvanse™ is a trademark of Shire Pharmaceuticals Ireland Ltd.

INTUNIV® is a registered trademark of Shire LLC.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995<
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  HeartIT is ... the first Cardiac Magnetic Resonance Solution in the ... within a standard web browser. Precession™ combines zero ... features unmatched in the industry. This provides CMR ... all the critical functions of a successful CMR ...
(Date:3/3/2015)... NEWARK, Calif. , March 3, 2015 Depomed, ... will be presenting at the 27 th Annual Roth ... presentation is scheduled for 12:30 pm ET (9:30 am PT) ... webcast, and the webcast can be accessed via the Investor ... A recording of the webcast will be archived for 30 ...
(Date:3/3/2015)... March 3, 2015  MabVax Therapeutics (OTCQB: MBVX), a cancer ... , the Company,s President and CEO, will be presenting at ... March 9 – 12, 2015 at the Ritz Carlton in ... MabVax,s presentation is scheduled for Wednesday, March 11 th , ... for review on the Investor Relations section of the Company,s ...
Breaking Medicine Technology:Precession Advances Medical Imaging by Delivering a Complete Cardiac Magnetic Resonance Platform in a Web Browser 2Depomed To Present At 27th Annual Roth Conference 2
... 25 BiPar Sciences, Inc., a,privately held biopharmaceutical ... has hired industry veterans Eric D. Malek as ... as vice president,for regulatory affairs. "Over the ... role in clinical,stage product partnerships involving major pharmaceutical ...
... ARBOR, Mich. Sept. 24 Velcura Therapeutics, Inc., ... with the,U.S. Food and Drug Administration (FDA) Sept. ... of VEL-0230, a drug developed to treat bone,disease. ... (IND),meeting was to obtain feedback from the FDA,s ...
Cached Medicine Technology:BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer 2Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease 2Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease 3
(Date:3/3/2015)... Mansfield, Texas (PRWEB) March 03, 2015 ... natural childbirth, announced today they now have over 130 ... Canada and 1 in Germany. In addition, the company ... joining their existing childbirth educator certification program . ... both mom and her birth partner. The practical information ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 March 3, ... for the 200th episode. The episode was a unique one, ... fourth season, but because it featured two men who were ... car accident. At the beginning of the episode, Deierlein said ... times on my radio show, but I’m very excited that ...
(Date:3/3/2015)... Presale tickets for Madonna will be ready for purchase ... March 9, with Madonna tour tickets expected to sell out ... talented artist is a significant one for fans, and the ... Ticketability.com to browse the inventory of Madonna tickets at ... enjoy, the 2015 tour is expected to attract attention from ...
(Date:3/3/2015)... 2015 Venato, a secure cloud-based ... their flagship software solution now provides an automated ... uploaded to the National Healthcare Safety Network (NHSN). ... (CMS) require that hospitals submit healthcare personnel (HCP) ... than May 15 for each influenza season in ...
(Date:3/3/2015)... Chicago has long been known as a premier ... a level of basketball to Chicago that the world had ... his Chicago Bulls days in the 1990’s. His brilliance created ... This era also witnessed the birth and rise of Nike ... rich basketball culture, US Sports Camps seeks to meet an ...
Breaking Medicine News(10 mins):Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2
... trouble finding that perfect,holiday gift? Maybe it,s time ... a healthier smile. , , ... , , Registered ... free and unrestricted use at http://www.mediaseed.tv . , ...
... China,s leading,research, consulting and IT outsourcing service provider, and ... Kong Stock Exchange:,HK08235), recently released its article on China,s ... In 2007, the rapid development of the ... in turn drove the development of medical insurance,policies. Benefiting ...
... Serving as a model for public health action on vitamin D, GrassrootsHealth, ... scientists, institutions and individuals committed to solving the worldwide vitamin D deficiency ... for health professionals at UC San Diego, December 2 from 8 a.m. ... ...
... other household members may be the most effective way of ... say a group of paediatric intensive care doctors on ... infectious disease which affects infants and young children. Vaccination is ... four months of age, with a further booster after three ...
... the presence of disinfecting solutions , , THURSDAY, Nov. 27 (HealthDay ... say Israeli researchers who found at least one pathogen in ... The tests of contact lens disinfection solution in the storage ... of severe corneal infections -- was the most common type ...
... from end-stage renal disease (ESRD), a growing number of ... (CHUM), have become the beneficiaries of a North American ... blood purification technique, HDF is indicated for ESRD patients. ... section, preliminary results show a clear advantage of high ...
Cached Medicine News:Health News:CCID Consulting Discusses China's Medical Equipment Market 2Health News:CCID Consulting Discusses China's Medical Equipment Market 3Health News:CCID Consulting Discusses China's Medical Equipment Market 4Health News:CCID Consulting Discusses China's Medical Equipment Market 5Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 3Health News:Parents of new babies should be considered for a whooping cough booster, say experts 2Health News:Contact Lens Cases Often Contaminated 2Health News:Major North American breakthrough for dialysis patients 2Health News:Major North American breakthrough for dialysis patients 3
... glucuronide (3alpha-diol G) is the glucuronide ... of dihydrotestosterone (DHT) [1,2]. 3alpha-diol G ... 75% of the bioactivity of testosterone ... product of intracellular reduction of DHT, ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... Gla protein, is a vitamin K-dependent, calcium ... of the noncollagenous bone matrix [1,2,3]. Osteocalcin ... a small amount produced by odontoblasts in ... formation, newly synthesized osteocalcin is incorporated into ...
... binding protein-2 (IGFBP-2) is one of six ... which specifically bind and modulate the actions ... of IGFBP-2 for IGF-II is estimated to ... suggesting a role in regulation of IGF-II ...
Medicine Products: